Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Stefanie, Koristka"'
Autor:
Claudia Arndt, Antje Tunger, Rebekka Wehner, Rebecca Rothe, Eleni Kourtellari, Stephanie Luttosch, Katharina Hannemann, Stefanie Koristka, Liliana R. Loureiro, Anja Feldmann, Torsten Tonn, Theresa Link, Jan Dominik Kuhlmann, Pauline Wimberger, Michael Philipp Bachmann, Marc Schmitz
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
The cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor palbociclib is an emerging cancer therapeutic that just recently gained Food and Drug Administration approval for treatment of estrogen receptor (ER)-positive, human epidermal growth factor recep
Externí odkaz:
https://doaj.org/article/d050e2b4207a49ff823ba99d4383286d
Autor:
Liliana R. Loureiro, Anja Feldmann, Ralf Bergmann, Stefanie Koristka, Nicole Berndt, Domokos Máthé, Nikolett Hegedüs, Krisztián Szigeti, Paula A. Videira, Michael Bachmann, Claudia Arndt
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-13 (2020)
Abstract Background Adapter chimeric antigen receptor (CAR) approaches have emerged has promising strategies to increase clinical safety of CAR T-cell therapy. In the UniCAR system, the safety switch is controlled via a target module (TM) which is ch
Externí odkaz:
https://doaj.org/article/a79309c630b94b63ab1652bbb82d83be
Autor:
Diana Lindner, Claudia Arndt, Liliana Rodrigues Loureiro, Anja Feldmann, Alexandra Kegler, Stefanie Koristka, Nicole Berndt, Nicola Mitwasi, Ralf Bergmann, Marcus Frenz, Michael P. Bachmann
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 14, p 7922 (2022)
Radiation of tumor cells can lead to the selection and outgrowth of tumor escape variants. As radioresistant tumor cells are still sensitive to retargeting of T cells, it appears promising to combine radio- with immunotherapy keeping in mind that the
Externí odkaz:
https://doaj.org/article/2c4bf13138b44996817bbaeb1cfed308
Autor:
Claudia Arndt, Liliana R. Loureiro, Anja Feldmann, Justyna Jureczek, Ralf Bergmann, Domokos Máthé, Nikolett Hegedüs, Nicole Berndt, Stefanie Koristka, Nicola Mitwasi, Frederick Fasslrinner, Chris Lamprecht, Alexandra Kegler, Anja Hoffmann, Tabea Bartsch, Ayşe Sedef Köseer, Gary Egan, Marc Schmitz, Vaclav Hořejší, Mechthild Krause, Anna Dubrovska, Michael Bachmann
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Induction or selection of radioresistant cancer (stem) cells following standard radiotherapy is presumably one of the major causes for recurrence of metastatic disease. One possibility to prevent tumor relapse is the application of targeted immunothe
Externí odkaz:
https://doaj.org/article/e9bde3c3ab474cab96ef8a34e0e398cf
Autor:
Anja Feldmann, Anja Hoffmann, Ralf Bergmann, Stefanie Koristka, Nicole Berndt, Claudia Arndt, Liliana Rodrigues Loureiro, Enrico Kittel-Boselli, Nicola Mitwasi, Alexandra Kegler, Chris Lamprecht, Karla Elizabeth González Soto, Michael Bachmann
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Chimeric antigen receptor (CAR) T cells show remarkable therapeutic effects in some hematological malignancies. However, CAR T cells can also cause life-threatening side effects. In order to minimize off-target and on-target/off-tumor reactions, impr
Externí odkaz:
https://doaj.org/article/bc91c804ed64427db2befd76169ff87f
Autor:
Claudia Arndt, Anja Feldmann, Stefanie Koristka, Martin Schäfer, Ralf Bergmann, Nicola Mitwasi, Nicole Berndt, Dominik Bachmann, Alexandra Kegler, Marc Schmitz, Edinson Puentes-Cala, Javier Andrés Soto, Gerhard Ehninger, Jens Pietzsch, Christos Liolios, Gerd Wunderlich, Jörg Kotzerke, Klaus Kopka, Michael Bachmann
Publikováno v:
OncoImmunology, Vol 8, Iss 11 (2019)
Chimeric antigen receptor (CAR) T cells have shown impressive therapeutic potential. Due to the lack of direct control mechanisms, therapy-related adverse reactions including cytokine release- and tumor lysis syndrome can even become life-threatening
Externí odkaz:
https://doaj.org/article/548a1789fc034041a40e5322349578b0
Autor:
Alexandra Kegler, Stefanie Koristka, Ralf Bergmann, Nicole Berndt, Claudia Arndt, Anja Feldmann, Anja Hoffmann, Martin Bornhäuser, Marc Schmitz, Michael P. Bachmann
Publikováno v:
OncoImmunology, Vol 8, Iss 9 (2019)
Adoptive transfer of chimeric antigen receptor (CAR)-equipped T cells have demonstrated astonishing clinical efficacy in hematological malignancies recently culminating in the approval of two CAR T cell products. Despite this tremendous success, CAR
Externí odkaz:
https://doaj.org/article/b77bd352929b49df88f188e5e0d8a43f
Autor:
Michael P. Bachmann, Tabea Bartsch, Claudia C. Bippes, Dominik Bachmann, Edinson Puentes-Cala, Jennifer Bachmann, Holger Bartsch, Claudia Arndt, Stefanie Koristka, Liliana R. Loureiro, Alexandra Kegler, Markus Laube, Joanne K. Gross, Tim Gross, Biji T. Kurien, R. Hal Scofield, A. Darise Farris, Judith A. James, Marc Schmitz, Anja Feldmann
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 3, p 1198 (2021)
Since the first description of nuclear autoantigens in the late 1960s and early 1970s, researchers, including ourselves, have found it difficult to establish monoclonal antibodies (mabs) against nuclear antigens, including the La/SS-B (Sjögrens’ s
Externí odkaz:
https://doaj.org/article/0daec652a4274e89b48cc285cd39a21e
Autor:
Susann Albert, Claudia Arndt, Anja Feldmann, Ralf Bergmann, Dominik Bachmann, Stefanie Koristka, Florian Ludwig, Pauline Ziller-Walter, Alexandra Kegler, Sebastian Gärtner, Marc Schmitz, Armin Ehninger, Marc Cartellieri, Gerhard Ehninger, Hans-Jürgen Pietzsch, Jens Pietzsch, Jörg Steinbach, Michael Bachmann
Publikováno v:
OncoImmunology, Vol 6, Iss 4 (2017)
Recent treatments of leukemias with chimeric antigen receptor (CAR) expressing T cells underline their impressive therapeutic potential. However, once adoptively transferred into patients, there is little scope left to shut them down after eliminatio
Externí odkaz:
https://doaj.org/article/440020276eed4d92a1364ec457dac05b
Autor:
Slava Stamova, Stefanie Koristka, Juliane Keil, Claudia Arndt, Anja Feldmann, Irene Michalk, Holger Bartsch, Claudia C. Bippes, Marc Schmitz, Marc Cartellieri, Michael Bachmann
Publikováno v:
Antibodies, Vol 1, Iss 2, Pp 172-198 (2012)
Immunotherapy has emerged as an alternative strategy to treat malignancies in addition to conventional radio- and chemotherapy. There has been a plethora of evidence that the immune system is able to control tumor outgrowth and a number of strategies
Externí odkaz:
https://doaj.org/article/598f0dfbfe6b406fb1c098a1b884ce6b